Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Innohep approved by FDA for DVT

July 20, 2000

FDA clears ConjuChem to initiate phase I/II trial of thrombin inhibitor

July 18, 2000

Berlex presents newly synthesized series of anticoagulants

July 17, 2000

Biopure reaches enrollment milestone in pivotal phase III trial of Hemopure

July 17, 2000

Novo Nordisk presents new heterocyclic inhibitors of factor VIIa-TF activity

July 12, 2000

Anticoagulant 2-pyridones under study at Sanofi-Synthelabo

July 10, 2000

Merck KGaA describes new series of compounds for thrombotic disorders

July 10, 2000

DuPont and Emisphere reach agreement on oral heparins

July 10, 2000

Antagonists of platelet adhesion receptor in development at Merck as antithrombotics

July 7, 2000

Anticoagulants from Berlex act by inhibiting factor Xa

July 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...